Menu Om Enzymatica - Affärsidé och mål - Hållbarhetsarbete - Jobba hos oss - Historik - Kontakta oss Forskning & Utveckling - Produktutveckling - Kliniska studier - Publikationer - Vetenskapliga rådgivare Produkter - ColdZyme® Munspray mot förkylning - Zymetech produkter Investerare - Aktieinformation - Ägare - Certified Advisor - Finansiella rapporter - Bolagsstyrning - Bolagsstämma - Valberedning - Styrelse - Utskott - Revisor - Ledning - Riktlinjer för ersättning - Bolagsordning - Bolagsbeskrivning First North - Presentationer - Bolagsanalyser - Kalender - IR-kontakt - Nyemission april 2016 Nyheter - Pressmeddelanden - Övriga nyheter - Prenumerera - Bildbank In English Our business concept is to offer effective help against some of our most common public diseases where viruses or bacteria play a crucial role. In this way, we contribute to improved health and increased well-being, which in turn can have positive health economic effects. Press releases 2017-09-25 Enzymatica AB: Notice of Extraordinary General Meeting regarding, among others, 2017-09-06 Enzymatica is recruiting CFO To the archive Financial reports 2017-07-20 Enzymatica Interim Report January-June 2017 2017-04-20 Enzymatica Interim Report January-March 2017 To the archive Other news 2017-06-21 Study on elite athletes shows that ColdZyme protects by providing fewer sick and… 2016-12-22 ColdZyme shows reduced sick leave during the cold season To the archive ABOUT ENZYMATICA Business concept and goals Sustainability work Work with us History Contact Us RESEARCH DEVELOPMENT Product development Clinical studies Publications Scientific advisors PRODUCTS ColdZyme® Mouth Spray for colds Zymetech products INVESTOR Stock information Financial reports Corporate governance Company description First North Presentations Company analyzes Calendar IR contact New issue April 2016 NEWS Press releases Other news Subscribe Image Bank CONTACT Ideon Science Park SE-223 70 Lund, Sweden Visit: Scheelevägen 19 Tel: +46 (0) 46-286 31 00 E-mail: info@enzymatica.se TWITTER Fetching Enzymatica tweets ... © 2014-2015 Enzymatica AB